Literature DB >> 7623445

A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyria.

J Vázquez-Prado1, F J Sánchez-Anzaldo, G J Ruiz-Argüelles, E Marín-López, E Lobato-Mendizábal.   

Abstract

A spectrophotometric method for porphobilinogen deaminase assay in erythrocytes is described. This test is determinant for the definite diagnosis of acute intermittent porphyria. In the method described, delta-aminolevulinic acid is used as substrate. Mercaptoethanol and zinc ions are introduced to maintain delta-aminolevulinic acid dehydratase in optimal conditions and to guarantee the in vitro production of porphobilinogen. An incubation temperature of 45 degrees C leads to the production of uroporphyrins, which are measured spectrophotometrically at 405 nm, giving reproducible results. The assay can be performed easily in any clinical laboratory and is valuable for detecting both patients and carriers of acute intermittent porphyria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623445     DOI: 10.1007/bf00711375

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria.

Authors:  X F Gu; F de Rooij; G Voortman; K Te Velde; Y Nordmann; B Grandchamp
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

2.  Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria.

Authors:  L R Peterson; P Hamernyik; T D Bird; R F Labbé
Journal:  Clin Chem       Date:  1976-11       Impact factor: 8.327

3.  The spectrophotometric determination of uroporphyrinogen I synthetase activity.

Authors:  B Grandchamp; N Phung; M Grelier; Y Nordmann
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

4.  A simple method for measuring erythrocyte porphobilinogenase, and its use in the diagnosis of acute intermittent porphyria.

Authors:  A M Batlle; E A Wider de Xifra; A M Stella
Journal:  Int J Biochem       Date:  1978

Review 5.  The porphyrias: recent advances.

Authors:  J T Hindmarsh
Journal:  Clin Chem       Date:  1986-07       Impact factor: 8.327

6.  Liquid-chromatographic analysis for urinary porphyrins.

Authors:  R E Ford; C N Ou; R D Ellefson
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

Review 7.  Molecular genetics of disorders of haem biosynthesis.

Authors:  G H Elder
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

Review 8.  International review of drugs in acute porphyria--1980.

Authors:  M R Moore
Journal:  Int J Biochem       Date:  1980

9.  Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation.

Authors:  M W Piepkorn; P Hamernyik; R F Labbé
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

10.  High prevalence of a point mutation in the porphobilinogen deaminase gene in Dutch patients with acute intermittent porphyria.

Authors:  X F Gu; F de Rooij; J S Lee; K Te Velde; J C Deybach; Y Nordmann; B Grandchamp
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

View more
  1 in total

1.  Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.

Authors:  Irene Paradisi; Sergio Arias
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.